In the November 17 issue of JAMA according to a report.

However, current evidence to support the usage of AEDs in hospitals has been limited and mixed to single-center studies. Also, these devices may be less effective or potentially dangerous when used in hospitals where only one 1 in 5 hospitalized patients have initial cardiac arrest rhythms that react to defibrillation. ‘Prior to the widespread dissemination of AEDs in hospitals, it becomes critical to show that AED make use of improves survival therefore,’ the authors create. Using data from the National Registry of Cardiopulmonary Resuscitation, Paul S. Chan, M.D., M.Sc., of Saint Luke’s Mid America Heart Institute, Kansas City, and co-workers evaluated the association of AED use and survival after an in-hospital cardiac arrest.5LINX enhancedcareMD is not a medical health insurance policy, but offers a practical method to quickly resolve routine healthcare concerns. After each consultation, members get a clinical report within their personal wellness portal for potential reference.. Aerovance reports top-line results from Aerovant Phase 2b clinical trial for eosinophilic asthma Aerovance Inc. Today announced top-line outcomes from its Phase 2b clinical trial that display the inhaled dry powder formulation of Aerovant works well in a pre-described subset of patients with eosinophilic asthma.004) in the incidence of asthma exacerbations in patients on Aerovant 10 mg twice daily treatment compared to placebo in the subset of patients with eosinophilic asthma, seeing that measured by elevated blood eosinophils.